Multibax's earnings have been declining at an average annual rate of -40.7%, while the Chemicals industry saw earnings growing at 7.3% annually. Revenues have been declining at an average rate of 2.1% per year. Multibax's return on equity is 8.3%, and it has net margins of 2.7%.
Key information
-40.75%
Earnings growth rate
-41.11%
EPS growth rate
Chemicals Industry Growth
8.05%
Revenue growth rate
-2.14%
Return on equity
8.34%
Net Margin
2.70%
Last Earnings Update
31 Mar 2026
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Multibax makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
SET:MBAX-R Revenue, expenses and earnings (THB Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
1,650
45
100
0
31 Dec 25
1,700
37
98
0
30 Sep 25
1,667
14
91
0
30 Jun 25
1,571
-15
89
0
31 Mar 25
1,482
-15
87
0
31 Dec 24
1,375
-20
84
0
30 Sep 24
1,308
11
82
0
30 Jun 24
1,244
23
82
0
31 Mar 24
1,143
-4
84
0
31 Dec 23
1,119
-38
86
0
30 Sep 23
1,282
-62
100
0
30 Jun 23
1,601
11
107
0
31 Mar 23
1,878
74
110
0
31 Dec 22
1,972
123
111
0
30 Sep 22
1,890
166
107
0
30 Jun 22
1,731
133
100
0
31 Mar 22
1,515
89
101
0
31 Dec 21
1,460
62
101
0
30 Sep 21
1,463
41
99
0
30 Jun 21
1,574
65
103
0
31 Mar 21
1,795
134
107
0
31 Dec 20
1,883
176
107
0
30 Sep 20
1,891
182
105
0
30 Jun 20
1,678
126
106
0
31 Mar 20
1,504
69
105
0
31 Dec 19
1,436
51
105
0
30 Sep 19
1,381
45
107
0
30 Jun 19
1,470
81
105
0
31 Mar 19
1,548
94
100
0
31 Dec 18
1,561
83
103
0
30 Sep 18
1,634
79
101
0
30 Jun 18
1,627
53
102
0
31 Mar 18
1,646
49
100
0
31 Dec 17
1,654
61
100
0
30 Sep 17
1,629
60
97
0
30 Jun 17
1,599
69
94
0
31 Mar 17
1,521
57
93
0
31 Dec 16
1,525
58
88
0
30 Sep 16
1,541
68
88
0
30 Jun 16
1,613
69
89
0
31 Mar 16
1,683
86
89
0
31 Dec 15
1,729
76
90
0
30 Sep 15
1,772
58
92
0
Quality Earnings: MBAX-R has high quality earnings.
Growing Profit Margin: MBAX-R became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MBAX-R's earnings have declined by 40.7% per year over the past 5 years.
Accelerating Growth: MBAX-R has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MBAX-R has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (21%).
Return on Equity
High ROE: MBAX-R's Return on Equity (8.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/13 11:04
End of Day Share Price
2026/07/13 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Multibax Public Company Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.